Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery

European Journal of Pharmaceutical Sciences

Volumn 38, Issue 3, 2009, Pages 206-214

  Alhalaweh, Amjad ^a   Andersson, Staffan ^a   Velaga, Sitaram P ^a  

^a LULEÅ UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Chitosan; Mucoadhesive; Nasal delivery; Spray drying; Zolmitriptan

Indexed keywords

CHITOSAN; ZOLMITRIPTAN;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRY POWDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGEN BOND; INFRARED SPECTROSCOPY; MOLECULAR WEIGHT; PARTICLE SIZE; PHASE SEPARATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SOLID STATE; SPRAY DRYING; THERMOGRAVIMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION; X RAY DIFFRACTION;

ADMINISTRATION, INTRANASAL; CAPSULES; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DRUG DELIVERY SYSTEMS; OXAZOLIDINONES; PARTICLE SIZE; POWDERS; TRYPTAMINES; X-RAY DIFFRACTION;

EID: 70349120301     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.07.003     Document Type: Article

References (41)

1. Asada M., Takahashi H., Okamoto H., Tanino H., and Danjo K. Theophylline particle design using chitosan by the spray drying. Int. J. Pharm. 270 (2004) 167-174
2. Aspden T.J., Mason J.D.T., Jones N.S., Lowe J., Skaugrud O., and Illum L. Chitosan as a nasal delivery system: the effect of chitosan on in vitro and in vivo mucociliary transport rates. J. Pharm. Sci. 86 (1997) 509-513
3. Aurora S.K., Kori S.H., Barrodale P., McDonald S.A., and Haseley D. Gastric stasis in migraine: more than just a paroxysmal abnormality during a migraine attack. Headache 46 (2006) 57-63
4. Bhandari B.R., and Howes T. Implication of glass transition for the drying and stability of dried foods. J. Food Eng. 40 (1999) 71-79
5. Burgess D.J., Duffy E., Etzler F., and Hickey A.J. Particle size analysis: AAPS Workshop Report, Cosponsored by the Food and Drug Administration and the United States Pharmacopeia. AAPS J. 6 (2004) 1-12
6. Chien Y., Kenneth S.E., and Su C.S.-F. Nasal Systemic Drug Delivery vol. 39 (1989), Marcel Dekker, New York
7. Chiou W.L., and Riegelman S. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60 (1971) 1281-1302
8. Clement E.M., and Franklin M. Simultaneous measurement of zolmitriptan and its major metabolites N-desmethyl zolmitriptan and zolmitriptan N-oxide in human plasma by high performance liquid chromatography with coulometric detection. J. Chromatogr. B: Biomed. Sci. Appl. 766 (2002) 339-343
9. Davis S.S., and Illum L. Absorption enhancers for nasal drug delivery. Clin. Pharmacokinet. 42 (2003) 1107-1128
10. Dodane V., Khan M.A., and Merwin J.R. Effect of chitosan on epithelial permeability and structure. Int. J. Pharm. 182 (1999) 21-32
11. Dong Y., Ruan Y., Wang H., Zhao Y., and Bi D. Studies on glass transition temperature of chitosan with four techniques. J. Appl. Polym. Sci. 93 (2004) 1553-1558
12. Drooge D.J.van., Hinrichs W.L.J., and Frijlink H.W. Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions. J. Control. Release 97 (2004) 441-452
13. Drooge D.J.van., Hinrichs W.L.J., Visser M.R., and Frijlink H.W. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques. Int. J. Pharm. 310 (2006) 220-229
14. Elversson J., Millqvist-Fureby A., Alderborn G., and Elofsson U. Droplet and particle size relationship and shell thickness of inhalable lactose particles during spray drying. J. Pharm. Sci. 92 (2003) 900-910
15. Gavini E., Hegge A.B., Rassu G., Sanna V., Testa C., Pirisino G., Karlsen J., and Giunchedi P. Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies. Int. J. Pharm. 307 (2006) 9-15
16. Gavini E., Rassu G., Muzzarelli C., Cossu M., and Giunchedi P. Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide. Eur. J. Pharm. Sci. 86 (2008) 245-252
17. Giunchedi P., Juliano C., Gavini E., Cossu M., and Sorrenti M. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug loaded chitosan microspheres. Eur. J. Pharm. Biopharm. 53 (2002) 233-239
18. Glen R.C., Martin G.R., Hill A.P., Hyde R.M., Woollard P.M., Salmon J.A., Buckingham J., and Robertson A.D. Computer-aided design and synthesis of 5-substituted tryptamines and their pharmacology at the 5-HT1D receptor: discovery of compounds with potential anti-migraine properties. J. Med. Chem. 38 (1995) 3566-3580
19. Illum L. Transport of drugs from the nasal cavity to the central nervous system. Eur. J. Pharm. Sci. 11 (2000) 1-18
20. Illum L., Farraj N.F., and Davis S.S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11 (1994) 1186-1189
21. Kaushal A.M., Chakraborti A.K., and Bansal A.K. FTIR studies on differential intermolecular association in the crystalline and amorphous states of structurally related non-steroidal anti-inflammatory drugs. Mol. Pharm. 5 (2008) 937-945
22. Kumer R.M.N.V. A review of chitin and chitosan applications. React. Funct. Polym. 46 (2000) 1-27
23. Learoyd T.P., Burrows J.L., French E., and Seville P.C. Modified release of beclometasone dipropionate from chitosan-based spray-dried respirable powders. Powder Technol. 187 (2008) 231-238
24. Lee K.Y., Kwon I.C., Kim Y.H., Jo W.H., and Jeong S.Y. Preparation of chitosan self-aggregates as a gene delivery system. J. Control. Release 51 (1998) 213-220
25. Lehr C.M., Bouwstra J.A., Schacht E.H., and Junginger H.E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78 (1992) 43-48
26. Martinac A., Filipovic-Grcic J., Barbaric M., Zorc B., Voinovich D., and Jalsenjak I. Gemfibrozil encapsulation and release from microspheres and macromolecular conjugates. Eur. J. Pharm. Sci. 17 (2002) 207-216
27. Marttin E., Romeijn S.G., Verhoef J.C., and Merkus F.W.H.M. Nasal absorption of dihydroergotamine from liquid and powder formulations in rabbits. J. Pharm. Sci. 86 (1997) 802-807
28. Mucha M., and Pawlak A. Thermal analysis of chitosan and its blends. Thermochim. Acta 427 (2005) 64-76
29. Nunthanid J., Laungtana-Anan M., Sriamornsak P., Limmatvapirat S., Puttipipatkhachorn S., Lim L.Y., and Khor E. Characterization of chitosan acetate as a binder for sustained release tablets. J. Control. Release 99 (2004) 15-26
30. Orienti I., Cerchiara T., Luppi B., Bigucci F., Zuccari G., and Zecchi V. Influence of different chitosan salts on the release of sodium diclofenac in colon-specific delivery. Int. J. Pharm. 238 (2002) 51-59
31. Pontiroli A.E., Calderara A., and Pozza G. Intranasal drug delivery: potential advantages and limitations from a clinical pharmacokinetic perspective. Clin. Pharmacokinet. 17 (1989) 299-307
32. ®). Expert. Rev. Neurother. 4 (2004) 33-41
33. Remuñãn-López C., and Bodmeier R. Mechanical, water uptake and permeability properties of crosslinked chitosan glutamate and alginate films. J. Control. Release 44 (1997) 215-225
34. Sakurai K., Maegawa T., and Takahashi T. Glass transition temperature of chitosan and miscibility of chitosan/poly(N-vinyl pyrrolidone) blends. Polymer 41 (2000) 7051-7056
35. Seshadri R., Zivanovic S., and Weiss J. Effect of acid solvent on the glass transition of solution-casted chitosan films. Southern Regional Meeting of the Society of Plastic Engineers. Knoxville, TN, November (2002)
36. Sinha V.R., Singla A.K., Wadhawan S., Kaushik R., Kumria R., Bansal K., and Dhawan S. Chitosan microspheres as a potential carrier for drugs. Int. J. Pharm. 274 (2004) 1-33
37. Soane R.J., Frier M., Perkins A.C., Jones N.S., Davis S.S., and Illum L. Evaluation of the clearance characteristics of bioadhesive systems in humans. Int. J. Pharm. 178 (1999) 55-65
38. Taylor L.S., and Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin as amorphous molecular dispersions. Pharm. Res. 14 (1997) 1691-1698
39. Van Der Schaaf, P.A., Blatter, F., Szelagiewicz, M., Berens, U., Paul, D.S., 2007. Crystalline forms of zolmitriptan. U.S. Patent Application 2007/0173536 A1 (July 6, 2007).
40. Vidgren M.T., and Kublik H. Nasal delivery systems and their effect on deposition and absorption. Adv. Drug Deliv. Rev. 29 (1998) 157-177
41. Yates R., Nairn K., Dixon R., and Seaber E. Preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray in healthy volunteers. J. Clin. Pharmacol. 42 (2002) 1237-1243